Marksans Pharma Ltd. (MARKSANS) Share Price Hits Fresh 52-Week High

Marksans Pharma Ltd. Share Price rose to Rs 284.1, up 1.86% today, and touched a fresh 52-week high. The company’s market capitalisation stands at Rs 12,301.13 crore.

Marksans Pharma Ltd. Share Price is in focus after the stock climbed to Rs 284.1 on 12 August 2026, up Rs 5.2 or 1.86% from the previous close of Rs 278.9, while touching a fresh 52-week high of Rs 284.1. At that level, the company’s market capitalisation stood at Rs 12,301.13 crore, placing it well above the median size of companies in the Healthcare sector snapshot supplied for this analysis.

For investors tracking Marksans Pharma Ltd. Share Price Today, the key verified development is straightforward: the stock reached a new one-year high during the session after opening at Rs 280.4, moving within a day range of Rs 277.3 to Rs 284.1. Turnover came in at Rs 1.29 crore with current volume of 45,398 shares. The supplied data confirms the price event and trading activity, but it does not establish a company-specific catalyst behind the move.

That still makes this a relevant Stock Market Today development. Fresh 52 Week High Stocks often draw attention because they reflect strong recent price performance and can influence search interest around Marksans Pharma Ltd. Stock News, Marksans Pharma Ltd. Share News and Marksans Pharma Ltd. Share Price Live. In this Univest analysis, the focus is on what the verified numbers show across price action, valuation, profitability, sector context and peer comparison, along with what investors may want to monitor next.

Marksans Pharma Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 284.1
Previous Close	Rs 278.9
Today's Change	+Rs 5.2 (+1.86%)
Day Open	Rs 280.4
Fresh 52-Week High	Rs 284.1
Day Low	Rs 277.3
Current Volume	45,398
Turnover	Rs 1.29 crore
Market Capitalisation	Rs 12,301.13 crore

Marksans Pharma Ltd. (MARKSANS) traded at Rs 284.1. versus the previous close of Rs 278.9, a rise of 1.86%. The stock opened at Rs 280.4, reached Rs 284.1, touched Rs 277.3. Reported volume was 45,398.

Marksans Pharma Ltd. Share Price Today shows a clear intraday push to a fresh 52-week high, with the stock opening at Rs 280.4, dipping to Rs 277.3, and then rising to Rs 284.1. The move left the stock 1.86% above the previous close, highlighting a positive session in absolute and percentage terms.

From a pure price-action perspective, Marksans Pharma Ltd. Share Price opened above the previous close of Rs 278.9 and stayed active inside a Rs 6.8 intraday band between the day low of Rs 277.3 and the day high of Rs 284.1. Because the day high and the 52-week high are both Rs 284.1, today’s session officially marked a fresh yearly high for the stock.

The day change of Rs 5.2 indicates that the stock added to recent momentum rather than merely testing resistance and fading back. That matters for traders scanning Top Gainers Today, Market Movers and Stocks in News, because a stock printing a new 52-week peak while closing above the previous close often attracts additional attention in Share Market Today discussions.

Participation was measurable but not unusually large in absolute rupee terms, with turnover at Rs 1.29 crore and volume at 45,398 shares. These figures confirm active trading in the counter, even though the supplied data does not attribute the move to any specific company announcement. For investors following Marksans Pharma Ltd. NSE or Marksans Pharma Ltd. BSE search trends, today’s verified takeaway is the price event itself: a new one-year high backed by a positive session move. That naturally shifts attention from price action to whether the stock’s fundamentals and valuation support continued investor interest, which is where the next section becomes important.

Marksans Pharma Ltd. (MARKSANS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 12,301.13 crore
P/E Ratio	31.07x
P/B Ratio	0.45x
ROE	-2.89%
ROCE	-0.26%

Marksans Pharma Ltd. was valued at a P/E ratio of 31.07x, a P/B ratio of 0.45x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	31.07x
Benchmark Median P/E	21.13x
Benchmark Average P/E	65.01x
Benchmark P/E Range	0x to 3,374.81x
Company P/B Ratio	0.45x
Benchmark Median P/B	1.9x
Company ROE	-2.89%
Benchmark Median ROE	10.92%
Company ROCE	-0.26%
Benchmark Median ROCE	13.29%
Company Market Capitalisation	Rs 12,301.13 crore
Benchmark Median Market Cap	Rs 142.81 crore

Marksans Pharma Ltd. (MARKSANS) is classified under sector: Healthcare.

Marksans Pharma Ltd. (MARKSANS) has a P/E ratio of 31.07x, which is above the benchmark median of 21.13x, a difference of +47.04%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Marksans Pharma Ltd. (MARKSANS) has a ROE of -2.89%, which is below the benchmark median of 10.92%, a difference of -126.47%. Marksans Pharma Ltd. (MARKSANS) has a ROCE of -0.26%, which is below the benchmark median of 13.29%, a difference of -101.96%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,949.87	31.07	0.45	-2.89	-0.26
Beta Drugs Ltd.	BETA	2,775.9	71.31	11.28	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,594.65	179.52	3.32	13.9	12.97
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,561.88	33.61	6.93	-2.6	16.92
NGL Fine-Chem Ltd.	NGLFINE	2,140.53	44.41	6.49	27.9	33.91

Marksans Pharma Ltd. (MARKSANS) has a P/E ratio of 31.07x compared with the displayed peer median of 44.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Marksans Pharma Ltd. (MARKSANS) has a market capitalisation of Rs 12,301.13 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Marksans Pharma Ltd.

This stock is drawing attention because the verified data combines a fresh price breakout with distinctive valuation and sector positioning. Marksans Pharma Ltd. Share Price is therefore relevant in both daily market coverage and broader stock analysis screens.

• Fresh 52-week high: The stock touched Rs 284.1, marking a new one-year high.
• Positive daily move: Marksans Pharma Ltd. Share Price Today rose 1.86%, or Rs 5.2, over the previous close of Rs 278.9.
• Intraday strength: The stock opened at Rs 280.4, traded as low as Rs 277.3 and climbed to the session high of Rs 284.1.
• Active trading: Turnover stood at Rs 1.29 crore with volume of 45,398 shares.
• Large market value: Market capitalisation of Rs 12,301.13 crore is well above the supplied Healthcare benchmark median and average.
• Mixed fundamentals: P/E is 31.07 and P/B is 0.45, while ROE is -2.89 and ROCE is -0.26.
• Sector context: The stock trades above the sector median P/E of 21.13 but below the sector median P/B of 1.9.

About Marksans Pharma Ltd.

Marksans Pharma Ltd. is being tracked here as part of the Healthcare sector and within the Pharmaceuticals & Drugs peer universe supplied in the comparative dataset. In practical terms, that places the company in a segment of the Indian Stock Market where valuation, profitability and scale are often judged against other listed healthcare and pharmaceutical businesses.

The current Univest coverage of Marksans Pharma Ltd. Company News is therefore centred on where the company sits in that listed ecosystem rather than on any unsupplied corporate profile detail. Based on the available benchmark and peer set, the business is being compared with companies such as Dishman Carbogen Amcis Ltd., Beta Drugs Ltd., Sai Parenteral's Ltd. and NGL Fine-Chem Ltd., all of which help frame Marksans Pharma Ltd. Share Price within a broader Healthcare context.

What stands out most from the available data is scale. With a market capitalisation of Rs 12,301.13 crore, the company is much larger than the peers listed in the supplied comparison and far above the sector median market value. For readers following Marksans Pharma Ltd. Latest News and Marksans Pharma Ltd. Shareholding Pattern searches on Univest, today’s focus remains the stock’s fresh 52-week high and how that price event sits alongside valuation and sector benchmarks.

Track Marksans Pharma Ltd. Share Price on Univest

Use Marksans Pharma Ltd. (MARKSANS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors who want to follow Marksans Pharma Ltd. Share Price more closely can use Univest to track live share price trends, 52-week levels, market capitalisation, valuation ratios, sector benchmarks and peer comparison in one place. That makes it easier to review Marksans Pharma Ltd. Share Price Today alongside broader Healthcare context without relying on a single datapoint.

Univest also helps users monitor stock analysis variables such as price action, market updates, peer positioning and company-specific trading milestones like a fresh 52-week high. For readers searching Marksans Pharma Ltd. Stock News, Marksans Pharma Ltd. Share Price Live or Marksans Pharma Ltd. News Today, the platform context is useful because it combines price movement with financial analysis rather than treating the day’s move in isolation.

As always, the main value in tracking the stock on Univest is not a recommendation but a structured way to monitor what changed, how the company compares with peers, and which verified metrics deserve attention after a new yearly high.

Frequently Asked Questions

What is the latest Marksans Pharma Ltd. Share Price Today?

Ans. Marksans Pharma Ltd. Share Price Today was Rs 284.1 at the time of this update. The stock was up Rs 5.2 or 1.86% from the previous close of Rs 278.9 and touched a fresh 52-week high.

Why is Marksans Pharma Ltd. Share Price in focus today?

Ans. The stock is in focus because it hit a fresh 52-week high of Rs 284.1 during the session. The supplied data confirms the price breakout, a 1.86% daily gain, and market capitalisation of Rs 12,301.13 crore.

What was the intraday range for Marksans Pharma Ltd. Share Price?

Ans. The stock opened at Rs 280.4, fell to a day low of Rs 277.3, and then climbed to a day high of Rs 284.1. That day high also became the new one-year high in today’s trade.

What is the fresh 52-week high for Marksans Pharma Ltd.?

Ans. The fresh 52-week high for Marksans Pharma Ltd. is Rs 284.1. The stock reached that level on 12 August 2026 while posting a gain of 1.86% over the previous closing price of Rs 278.9.

What does the market cap of Marksans Pharma Ltd. indicate?

Ans. Marksans Pharma Ltd. had a market capitalisation of Rs 12,301.13 crore in the supplied data. That is far above the Healthcare sector median of Rs 142.81 crore and the sector average of Rs 461.64 crore.

How is Marksans Pharma Ltd. valued on P/E and P/B?

Ans. The stock is valued at a P/E ratio of 31.07 and a P/B ratio of 0.45. Its P/E is above the Healthcare sector median of 21.13, while its P/B is below the sector median of 1.9.

What do the ROE and ROCE figures show for Marksans Pharma Ltd.?

Ans. The supplied figures show ROE of -2.89 and ROCE of -0.26 for Marksans Pharma Ltd. Both are below the Healthcare sector medians of 10.92 for ROE and 13.29 for ROCE in the benchmark snapshot.

How active was trading in Marksans Pharma Ltd. stock today?

Ans. Trading activity showed current volume of 45,398 shares and turnover of Rs 1.29 crore. These figures confirm participation in the counter as Marksans Pharma Ltd. Share Price moved to a fresh 52-week peak.

How does Marksans Pharma Ltd. compare with peers?

Ans. Marksans Pharma Ltd. has a market cap of Rs 12,301.13 crore, above peers such as Beta Drugs, NGL Fine-Chem and Dishman Carbogen Amcis in the supplied list. Its P/B is lower, but its ROE and ROCE are weaker.

What should investors monitor next in Marksans Pharma Ltd. Share Price?

Ans. Investors may track whether the stock sustains above the fresh 52-week high of Rs 284.1, while also watching valuation ratios, profitability measures such as ROE and ROCE, and the company’s position versus Healthcare sector benchmarks.